Literature DB >> 7733647

Low doses of anticancer drugs increase susceptibility of tumor cells to lysis by autologous killer cells.

H Matsuoka1, M Eura, K Chikamatsu, K Nakano, Y Kanzaki, K Masuyama, T Ishikawa.   

Abstract

Pretreatment of squamous cell carcinoma (SCC) cells from four patients with low doses of cisplatin, carboplatin or 5-fluorouracil increased the susceptibility to lysis by autologous killer cells in vitro. Exposure of two SCC cell lines to low doses of these drugs increased the cell surface expression of both HLA class I and intercellular adhesion molecule-1 (ICAM-1). HLA class II, neural cell adhesion molecule and B7 were not expressed on the cell surface before or after such treatment. The results suggest that these drugs increase the susceptibility of tumor cells to autologous cell-mediated cytotoxicity, at least in part, by enhancing the expression of HLA class I and ICAM-1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733647

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.

Authors:  Annika Nelde; Daniel J Kowalewski; Linus Backert; Heiko Schuster; Jan-Ole Werner; Reinhild Klein; Oliver Kohlbacher; Lothar Kanz; Helmut R Salih; Hans-Georg Rammensee; Stefan Stevanović; Juliane S Walz
Journal:  Oncoimmunology       Date:  2018-02-14       Impact factor: 8.110

Review 2.  Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A Review.

Authors:  Ananthan Sadagopan; Theodoros Michelakos; Gabriella Boyiadzis; Cristina Ferrone; Soldano Ferrone
Journal:  JAMA Oncol       Date:  2022-03-01       Impact factor: 31.777

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.